07:29 AM EDT, 07/19/2024 (MT Newswires) -- Augmedix ( AUGX ) said Friday it has agreed to be acquired by Commure in an all-cash deal valued at about $139 million.

Under the terms of the deal, Augmedix ( AUGX ) shareholders will get $2.35 per share upon deal completion. This represents a 169% premium over the volume-weighted average price of the company's shares for the 30 days ending Thursday.

The deal, which has already been approved by Augmedix's ( AUGX ) board, is expected to close in late Q3 or early Q4, subject to stockholder approval and customary conditions.

Upon deal completion, Augmedix ( AUGX ) will become a privately held subsidiary of Commure.